News and media
News and media
Discover the latest news about motor neurone disease (MND) advocacy and research or visit our one-stop-shop for media,
Media hub.
Got a story to share?
Tell us about how MND has impacted your life.
News List
Morag Millington | 16/10/2019
MNDRIA, the research arm of MND Australia, has today announced close to $3 million in new research grants to further understand the causes, find effective treatments and discover a cure for motor neurone disease (MND).
Morag Millington | 29/08/2019
It is with great sadness that in August we will be saying goodbye to Janet Nash who, after 25 years with our national network of MND associations, is leaving to start her well-earned retirement.
Morag Millington | 16/08/2019
MNDRIA is pleased to announce that 10 PhD students and early career researchers have been awarded Jenny and Graham Lang Travel Grants to attend the International Symposium on ALS/MND in Perth in December 2019.
Morag Millington | 19/07/2019
The Lighthouse Project has just announced promising results from their phase 2 clinical trial, which will now progress onto a much larger phase 3 trial.
Morag Millington | 2/05/2019
MND Australia is seeking six commitments from candidates from all sides of politics in the lead up to the 2019 Federal Election, to address the urgent need to improve the lives of people living with motor neurone disease.
Carol Birks | 8/04/2019
MND Australia has responded to last weeks Federal Budget with a call for the Federal Government to substantially increase investment in aged care to address the disability needs of older Australians.
Morag Millington | 19/03/2019
Teglutik®, the liquid formulation of riluzole, will be added to the PBS from 1 April 2019.
Laura Birks | 28/02/2019
MNDRIA is pleased to announce the recipients of the 2019-2021 PhD Scholarship Top-up Grants. These grants encourage early career researchers to focus their research on finding cures, treatments and better care for people with MND Read more
| 19/02/2019
Late last year MND Australia attended the Annual International ALS/MND Meetings hosted by MND Scotland in Glasgow.
| 8/02/2019
Reports on a phase 1 clinical trial into Copper-ATSM recently gained global media attention. Take a look at what the experts have to say.